BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7979845)

  • 1. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
    Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.
    Ziegler EJ; Fisher CJ; Sprung CL; Straube RC; Sadoff JC; Foulke GE; Wortel CH; Fink MP; Dellinger RP; Teng NN
    N Engl J Med; 1991 Feb; 324(7):429-36. PubMed ID: 1988827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies.
    Barriere SL; Guglielmo BJ
    Clin Pharm; 1992 Mar; 11(3):223-35. PubMed ID: 1611812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current practice in nutritional support and its association with mortality in septic patients--results from a national, prospective, multicenter study.
    Elke G; Schädler D; Engel C; Bogatsch H; Frerichs I; Ragaller M; Scholz J; Brunkhorst FM; Löffler M; Reinhart K; Weiler N;
    Crit Care Med; 2008 Jun; 36(6):1762-7. PubMed ID: 18496367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal failure in patients with severe sepsis and septic shock--a significant independent risk factor for mortality: results from the German Prevalence Study.
    Oppert M; Engel C; Brunkhorst FM; Bogatsch H; Reinhart K; Frei U; Eckardt KU; Loeffler M; John S;
    Nephrol Dial Transplant; 2008 Mar; 23(3):904-9. PubMed ID: 18065435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.
    Nguyen HB; Corbett SW; Steele R; Banta J; Clark RT; Hayes SR; Edwards J; Cho TW; Wittlake WA
    Crit Care Med; 2007 Apr; 35(4):1105-12. PubMed ID: 17334251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arriving by emergency medical services improves time to treatment endpoints for patients with severe sepsis or septic shock.
    Band RA; Gaieski DF; Hylton JH; Shofer FS; Goyal M; Meisel ZF
    Acad Emerg Med; 2011 Sep; 18(9):934-40. PubMed ID: 21883637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock.
    Artero A; Zaragoza R; Camarena JJ; Sancho S; González R; Nogueira JM
    J Crit Care; 2010 Jun; 25(2):276-81. PubMed ID: 20149587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time- and fluid-sensitive resuscitation for hemodynamic support of children in septic shock: barriers to the implementation of the American College of Critical Care Medicine/Pediatric Advanced Life Support Guidelines in a pediatric intensive care unit in a developing world.
    Oliveira CF; Nogueira de Sá FR; Oliveira DS; Gottschald AF; Moura JD; Shibata AR; Troster EJ; Vaz FA; Carcillo JA
    Pediatr Emerg Care; 2008 Dec; 24(12):810-5. PubMed ID: 19050666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Predisposition, Insult/Infection, Response, and Organ dysfunction, Acute Physiology And Chronic Health Evaluation II, and Mortality in Emergency Department Sepsis in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle.
    Nguyen HB; Van Ginkel C; Batech M; Banta J; Corbett SW
    J Crit Care; 2012 Aug; 27(4):362-9. PubMed ID: 22033054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand.
    ;
    Crit Care Resusc; 2007 Mar; 9(1):8-18. PubMed ID: 17352661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group.
    Derkx B; Wittes J; McCloskey R
    Clin Infect Dis; 1999 Apr; 28(4):770-7. PubMed ID: 10825037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intravenous unfractionated heparin and mortality in septic shock.
    Zarychanski R; Doucette S; Fergusson D; Roberts D; Houston DS; Sharma S; Gulati H; Kumar A
    Crit Care Med; 2008 Nov; 36(11):2973-9. PubMed ID: 18824906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated acute myocardial infarction requiring mechanical ventilation in the intensive care unit: prognostic factors of clinical outcome in a series of 157 patients.
    Lesage A; Ramakers M; Daubin C; Verrier V; Beynier D; Charbonneau P; du Cheyron D
    Crit Care Med; 2004 Jan; 32(1):100-5. PubMed ID: 14707566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study.
    Sakr Y; Reinhart K; Vincent JL; Sprung CL; Moreno R; Ranieri VM; De Backer D; Payen D
    Crit Care Med; 2006 Mar; 34(3):589-97. PubMed ID: 16505643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial.
    Busund R; Koukline V; Utrobin U; Nedashkovsky E
    Intensive Care Med; 2002 Oct; 28(10):1434-9. PubMed ID: 12373468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.